HOLLY CRAWFORD: Open Payments
NPI 1154804367 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,835 in 75 payments from 12 companies in 2025. Trend: 2023 $460 · 2024 $1,168 · 2025 $1,835
Food & beverage: $1,736Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 16 | $501 |
| ABBVIE INC. | 24 | $407 |
| Madrigal Pharmaceuticals | 5 | $217 |
| GENZYME CORPORATION | 2 | $147 |
| Amgen Inc. | 1 | $125 |
| Aimmune Therapeutics, Inc. | 5 | $97 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $92 |
| PFIZER INC. | 4 | $77 |
| Ardelyx, Inc. | 4 | $61 |
| Phathom Pharmaceuticals, Inc. | 7 | $48 |
Products named: TREMFYA, REZDIFFRA, RINVOQ, DUPIXENT, REPATHA, SKYRIZI, LINZESS, ZENPEP.
Industry payments across FL — which companies pay providers there.
